However, initial studies using bevacizumab (anti-VEGF) did not reach statistical significance regarding OS [ 25 ].
← all excerpts
Differentially Expressed Genes and Signaling Pathways Potentially Involved in Primary Resistance to Chemo-Immunotherapy in Advanced-Stage Gastric Cancer Patients.
1
—
—